Stage IV Colorectal Cancer Active Not Recruiting Phase 2 Trials for Atezolizumab (DB11595)

IndicationStatusPhase
DBCOND0042053 (Stage IV Colorectal Cancer)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02873195Capecitabine and Bevacizumab With or Without Atezolizumab in Treating Patients With Refractory Metastatic Colorectal CancerTreatment